AUtoimmunity PRofile in INterferon beta-1a treated multiple sclerosis patients. The AUPRIN Study: Comparison of 2 different dosages of subcutaneous interferon beta-1a

被引：0
|
作者：
Verdun, E
Giordano, L
Cucci, MA
Ricci, A
Barbero, P
Pipieri, A
Clerico, M
Aimo, G
Durelli, L
机构：
来源：
NEUROLOGY | 2005年 / 64卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：A384 / A385
页数：2
相关论文
共 50 条
  • [1] Occurrence of autoimmune events during treatment with two different dosages of subcutaneous interferon beta-1a (Rebif®) in multiple sclerosis:: the AUtoimmunity PRofile in INterferon beta (AUPRIN) study
    Giordano, L.
    Barbero, P.
    Clerico, M.
    Pipieri, A.
    Versino, E.
    Ferrero, B.
    Contessa, G.
    Delfico, L.
    Durelli, L.
    MULTIPLE SCLEROSIS, 2006, 12 : S208 - S208
  • [2] The AUtoimmunity PRofile in INterferon beta (AUPRIN) study: occurrence of autimmune events during treatment with two different dosages of subcutaneous Interferon beta-1a (Rebif)
    Durelli, L.
    Barbero, P.
    Clerico, M.
    Contessa, G.
    Pipieri, A.
    Giordano, L.
    JOURNAL OF NEUROLOGY, 2006, 253 : 83 - 83
  • [3] Risk of stroke in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Sabido-Espin, M.
    Venkatesh, S.
    Aldridge, J.
    Gillett, A.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 1022 - 1022
  • [4] AUtoimmunity PRofile in INterferon β-1a treated multiple sclerosis patients.: The AUPRIN study:: comparison of 2 different dosage of subcutaneous interferon-β-1a
    Verdun, E
    Ricci, A
    Cucci, MA
    Barbero, P
    Pipieri, A
    Clerico, M
    Giordano, L
    Delfico, L
    Tassinari, T
    Motti, L
    Paciello, M
    Reggio, A
    Aimo, G
    Durelli, L
    MULTIPLE SCLEROSIS, 2004, 10 (7032): : S251 - S251
  • [5] COMPARISON OF MEDICATION ADHERENCE TO INTERFERON BETA-1B AND INTERFERON BETA-1A SUBCUTANEOUS IN MULTIPLE SCLEROSIS PATIENTS
    Meletiche, D. M.
    Kozma, C.
    Dickson, M.
    VALUE IN HEALTH, 2009, 12 (03) : A194 - A194
  • [6] Evaluation of the risk of malignancies in patients with multiple sclerosis treated with subcutaneous interferon beta-1a
    Alteri, E.
    Kornmann, G.
    Moraga, M. Stam
    Casset-Semanaz, F.
    Miret, M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2009, 285 : S204 - S205
  • [7] Subcutaneous Interferon Beta-1a in Pediatric Multiple Sclerosis: A Retrospective Study
    Tenembaum, Silvia N.
    Banwell, Brenda
    Pohl, Daniela
    Krupp, Lauren B.
    Boyko, Alexey
    Meinel, Michael
    Lehr, Lorenz
    Rocak, Sanda
    di Cantogno, Elisabetta Verdun
    Moraga, Margaretha Stam
    Ghezzi, Angelo
    JOURNAL OF CHILD NEUROLOGY, 2013, 28 (07) : 849 - 856
  • [8] Rebif - Interferon beta-1a - SERONO - Second interferon beta-1a product for relapsing multiple sclerosis
    不详
    FORMULARY, 2002, 37 (04) : 169 - 169
  • [9] Risk of Stroke in Patients with Multiple Sclerosis Treated with Subcutaneous Interferon beta-1a (scIFNβ-1a)
    Sabido, Meritxell
    Venkatesh, Saritha
    Aldridge, Julie
    Gillett, Alan
    NEUROLOGY, 2018, 90
  • [10] Subcutaneous Interferon beta-1a Treatment and Pregnancy Outcomes in Patients with Multiple Sclerosis
    Sandberg-Wollheim, Magnhild
    Alteri, Enrica
    Moraga, Margaretha Stam
    Kornmann, Gabrielle
    NEUROLOGY, 2010, 74 (09) : A404 - A404
12345